drug discovery

/Tag: drug discovery

ELRIG Pharmaceutical Flow Cytometry and Imaging

2020-05-13T08:03:59+00:00

Metrion Biosciences' Sales and Marketing Manager Dr Sophie Rose is looking forward to attending the ELRIG event Pharmaceutical Flow Cytometry and Imaging to be held at GlaxoSmithKlein (GSK) in Stevenage on 24 and 25 November 2020. Please email info@metrionbiosciences.com if you wish to arrange a meeting with Sophie at the event or if you would [...]

ELRIG Pharmaceutical Flow Cytometry and Imaging2020-05-13T08:03:59+00:00

ELRIG Drug Discovery 2020

2020-03-24T15:53:46+00:00

Metrion Biosciences will be attending the ELRIG Drug Discovery 2020 meeting to be held at the ExCeL arena in London from 6th to 7th October 2020. Please email info@metrionbiosciences.com if you wish to arrange a meeting with one of our attendees. Metrion Biosciences is a UK-based Contract Research Organization (CRO) located within the Cambridge bio [...]

ELRIG Drug Discovery 20202020-03-24T15:53:46+00:00

Safety Pharmacology Society Annual Meeting (2020)

2020-03-24T15:27:31+00:00

Metrion Biosciences look forward to attending, presenting posters and exhibiting at the Safety Pharmacology Society (SPS) Annual Meeting to be held in Montreal, Canada from 13th to 16th September 2020. Metrion will be located at Booth # 218 in the exhibits hall for the duration of the event. Poster titles to be confirmed shortly. Please [...]

Safety Pharmacology Society Annual Meeting (2020)2020-03-24T15:27:31+00:00

Metrion Biosciences and International Scientific Consortium publish data and new recommendations for in vitro risk assessment of the cardiac safety of new medicines

2020-05-11T12:31:08+00:00

Metrion Biosciences and International Scientific Consortium publish data and new recommendations for in vitro risk assessment of the cardiac safety of new medicines Part of the US FDA’s Comprehensive in vitro Proarrythmia Assay (CiPA) Initiative Cambridge, UK, 07 April 2020: Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, today [...]

Metrion Biosciences and International Scientific Consortium publish data and new recommendations for in vitro risk assessment of the cardiac safety of new medicines2020-05-11T12:31:08+00:00

Metrion-Nanion Collaborative Webinar: Validation and optimisation of automated patch clamp voltage-gated Ca2+ channel assays

2020-04-10T19:04:07+00:00

Metrion Biosciences and Nanion Technologies look forward to hosting their first collaborative webinar on Tuesday 28th April entitled: Validation and optimization of automated patch clamp voltage-gated Ca2+ channel assays. The webinar will feature Metrion's CSO Dr. Marc Rogers. Marc will outline the development, optimisation and validation of a range of voltage-gated Ca2+ channel assays on [...]

Metrion-Nanion Collaborative Webinar: Validation and optimisation of automated patch clamp voltage-gated Ca2+ channel assays2020-04-10T19:04:07+00:00

RSC Ion Channel Symposium

2019-07-29T15:39:14+00:00

Metrion Biosciences are sponsoring and exhibiting (booth number to be added at a later date) at the RSC Ion Channel Symposium taking place from Monday 24th- Tuesday 25th February 2020 at the Wellcome Trust Genome Campus Conference Centre, Hinxton, Cambridge. Metrion will also be presenting a poster (title to be added at a later date). [...]

RSC Ion Channel Symposium2019-07-29T15:39:14+00:00

64th Annual Meeting of the Biophysical Society

2020-01-27T17:12:30+00:00

Metrion Biosciences will be attending and exhibiting at the 64th Annual Meeting of the Biophysical Society to be held at the San Diego Convention Centre in San Diego, California from 15th - 19th February 2020. Metrion will be exhibiting at booth number 214 in the Exhibits Hall for the duration of the meeting and will [...]

64th Annual Meeting of the Biophysical Society2020-01-27T17:12:30+00:00

Metrion Biosciences and LifeArc extend ion channel drug discovery collaboration

2019-12-03T08:32:31+00:00

Metrion Biosciences and LifeArc extend ion channel drug discovery collaboration to accelerate neuroscience-focused research Initial twelve month collaboration successfully identifies hit compounds and progresses into hit-to-lead optimisation phase Cambridge and London, UK, 03 December 2019: Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, and LifeArc, a leading UK independent medical [...]

Metrion Biosciences and LifeArc extend ion channel drug discovery collaboration2019-12-03T08:32:31+00:00

Why Metrion’s CSO spent 35 years unlocking the potential of ion channels for drug discovery

2020-03-04T09:13:21+00:00

Thank you to the ELRIG Committee and to BioStrata for allowing us to share the below content on our website. The British Pharmacological Society (BPS) ran a special symposium at the ELRIG Drug Discovery 2019 conference yesterday, focused on the importance of targeting ion channels for drug discovery.  As a unique platform to foster the [...]

Why Metrion’s CSO spent 35 years unlocking the potential of ion channels for drug discovery2020-03-04T09:13:21+00:00

ELRIG Drug Discovery 2019

2019-11-01T15:02:04+00:00

Metrion Biosciences will be attending ELRIG Drug Discovery 2019 to be held at the ACC Arena, Liverpool on 5th and 6th November 2019. Dr Marc Rogers, Chief Scientific Officer, will be presenting an ion channel drug discovery focused talk at 12.10-12.30 during the British Pharmacology Society track 'Targeting Ion Channels for Drug Discovery" which takes [...]

ELRIG Drug Discovery 20192019-11-01T15:02:04+00:00